
Cefipark S 1000mg/500mg Injection
Marketer
Park Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefipark S 1000mg/500mg Injection
Cefipark S, a 1000mg/500mg injectable dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed treatment schedule is crucial; premature cessation may compromise efficacy. Complete the full course, even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occur. Sufficient rest, balanced nutrition, and adequate hydration are recommended for optimal recovery. Your doctor may order lab tests to monitor treatment effectiveness.
Uses of Cefipark S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Cefipark S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefipark S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefipark S 1000mg/500mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.
How Cefipark S 1000mg/500mg Injection works:
Cefipark S, a 1000mg/500mg injectable formulation, unites Ceftriaxone, a broad-spectrum antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Cefipark S 1000mg/500mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefipark S (1000mg/500mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Cefipark S 1000mg/500mg injection requires careful consideration when breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cefipark S 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefipark S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Cefipark S 1000mg/500mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Cefipark S 1000mg/500mg Injection is not suggested for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Cefipark S 1000mg/500mg Injection :
Omitting a scheduled dose of Cefipark S 1000mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Cefipark S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
